Institutional investors purchased a net $5.6 million shares of TSRO during the quarter ended December 2012, and now own 38.07% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Mutual fund holders | 8.96% |
| Individual stakeholders | 57.98% |
| Other institutional | 29.11% |